Climb Bio (CLYM) Operating Leases (2022 - 2026)

Climb Bio (CLYM) has 5 years of Operating Leases data on file, last reported at $216000.0 in Q1 2026.

• Quarterly Operating Leases fell 32.29% year-over-year to $216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216000.0 (down 32.29% YoY) and the FY2025 annual result came in at $285000.0, down 24.0% from the prior year.
• Operating Leases eased to $216000.0 in Q1 2026, from $285000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $571000.0 in Q3 2022 to a low of $15000.0 in Q4 2023.
• A 5-year average of $267714.3 and a median of $270500.0 in 2022 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases plunged 91.67% — and 2024, when it jumped 2400.0%.
• Tracing CLYM's Operating Leases over 5 years: stood at $180000.0 in 2022, then sank by 91.67% to $15000.0 in 2023, then jumped by 2400.0% to $375000.0 in 2024, then dropped by 24.0% to $285000.0 in 2025, then slipped by 24.21% to $216000.0 in 2026.
• The last three Operating Leases figures came in at $216000.0 (Q1 2026), $285000.0 (Q4 2025), and $352000.0 (Q3 2025), per Business Quant data.